CClinicalTrials.gg
Not yet recruitingNCT07686822Updated Jul 7, 2026

Spinal Cord Stimulation Combined With Motor Imagery Brain-Computer Interface for Chronic Post-Stroke Upper Limb Motor Dysfunction

An interventional study of Spinal Cord Stimulation and Motor Imagery Brain-Computer Interface Rehabilitation Training in Chronic Stroke, sponsored by Zhejiang Provincial People's Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Zhejiang Provincial People's Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
66
Allocation
Non-randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This clinical study aims to evaluate the efficacy and safety of spinal cord stimulation combined with non-invasive motor imagery brain-computer interface rehabilitation training in patients with upper limb motor dysfunction after chronic stroke. The study includes an experimental group receiving spinal cord stimulation combined with motor imagery brain-computer interface rehabilitation training and a control group receiving motor imagery brain-computer interface rehabilitation training alone. The primary outcome is upper limb motor function assessed by the Fugl-Meyer Assessment for Upper Extremity. Secondary outcomes include muscle tone, upper limb functional activity, activities of daily living, adverse events, serious adverse events, and exploratory neurophysiological and neuroimaging indicators.

Read the detailed description

Upper limb motor dysfunction is a common and disabling sequela of stroke. Many patients enter a chronic phase more than 6 months after stroke onset, during which spontaneous recovery and conventional rehabilitation-related improvement often reach a plateau. Motor imagery brain-computer interface rehabilitation can decode motor intention from electroencephalographic signals and provide closed-loop feedback through external devices, thereby promoting cortical reorganization. However, in patients with impaired corticospinal pathways and insufficient residual motor execution capacity, the efficacy of motor imagery brain-computer interface training alone may be limited.

Spinal cord stimulation may facilitate spinal motor circuits, reduce abnormal muscle tone, and improve the excitability of residual descending motor pathways. Combining spinal cord stimulation with motor imagery brain-computer interface training may provide a synergistic central-peripheral neuromodulation strategy. The brain-computer interface decodes motor intention from the central nervous system, while spinal cord stimulation facilitates peripheral motor pathway execution, potentially enhancing motor recovery and neuroplasticity.

Participants will be assigned, according to patient preference and investigator assessment, to either the experimental group or the control group. The experimental group will undergo spinal cord stimulation implantation followed by individualized stimulation programming and standardized motor imagery brain-computer interface rehabilitation training. The control group will receive the same frequency and duration of motor imagery brain-computer interface rehabilitation training without spinal cord stimulation implantation. Clinical outcomes will be assessed at baseline, after 4 weeks of intervention, 2 months after intervention, and 3 months after intervention. Safety events will be recorded throughout the study. Exploratory assessments will include electroencephalography and neuroimaging to investigate potential mechanisms of neuroplasticity.

02

Conditions studied

  • Chronic Stroke

Keywords

  • Stroke rehabilitation
  • Upper limb motor dysfunction
  • Spinal cord stimulation
  • Motor imagery brain-computer interface
  • Brain-computer interface
  • Neuromodulation
  • Neuroplasticity
  • Upper limb rehabilitation
03

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18 to 75 years.
  • First-ever unilateral supratentorial stroke, either ischemic or hemorrhagic, confirmed by computed tomography or magnetic resonance imaging, resulting in hemiparesis, with disease duration longer than 6 months.
  • At least one active movement in the wrist or fingers of the affected upper limb, with muscle strength of grade 1 or higher.
  • Fugl-Meyer Assessment for Upper Extremity score between 10 and 40, indicating moderate upper limb motor impairment.
  • Change in Fugl-Meyer Assessment score less than 10% within the previous month, indicating a functional plateau.
  • Clear consciousness and basically normal cognitive function, with Mini-Mental State Examination score of 24 or higher.
  • Stable clinical condition and ability to understand and cooperate with simple instructions and rehabilitation training.
  • Written informed consent voluntarily signed by the participant or legal guardian.

Exclusion criteria

Exclusion Criteria:

  • Other neurological diseases that may cause motor dysfunction, such as Parkinson's disease, multiple sclerosis, or spinal cord injury.
  • Severe visual or auditory impairment that prevents cooperation with visual or auditory feedback instructions of the brain-computer interface system.
  • Contraindications to spinal cord stimulation surgery, such as severe coagulation dysfunction, infection at the puncture site, severe spinal deformity, or spinal canal stenosis.
  • History of epilepsy, intracranial metal implants, cardiac pacemaker, or other contraindications to magnetic resonance imaging.
  • Previous neuromodulation surgery for hemiparesis, such as spinal cord stimulation or deep brain stimulation.
  • Pregnancy or lactation.
  • Any other condition judged by the investigator to make the participant unsuitable for this study.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
66 participants (estimated)

Study arms

  • Experimental
    Spinal Cord Stimulation Combined With Motor Imagery Brain-Computer Interface Training

    Participants in this group will undergo spinal cord stimulation implantation followed by individualized stimulation programming. After stabilization of stimulation parameters, participants will receive standardized motor imagery brain-computer interface rehabilitation training for 4 weeks, 5 sessions per week.

    Device: Spinal Cord Stimulation · Device: Motor Imagery Brain-Computer Interface Rehabilitation Training

  • Active comparator
    Motor Imagery Brain-Computer Interface Rehabilitation Training

    Participants in this group will receive the same frequency and duration of standardized motor imagery brain-computer interface rehabilitation training as the experimental group, for 4 weeks, 5 sessions per week. Training equipment, motor imagery tasks, and feedback methods will be consistent with those used in the experimental group.

    Device: Motor Imagery Brain-Computer Interface Rehabilitation Training

Interventions

  • DeviceSpinal Cord Stimulation

    Spinal cord stimulation will be delivered through epidural electrodes implanted at cervical spinal cord levels, typically C3-C7 for upper limb dysfunction. Stimulation parameters will be individually optimized within clinically safe and device-permitted ranges, including frequency, pulse width, amplitude, electrode configuration, and stimulation mode.

  • DeviceMotor Imagery Brain-Computer Interface Rehabilitation Training

    Motor imagery brain-computer interface training will use a 64-channel medical-grade electroencephalography cap to acquire scalp EEG signals. Participants will perform motor imagery tasks involving the affected upper limb, such as grasping, elbow extension, or wrist lifting. Sensorimotor rhythm features, especially mu rhythm and beta rhythm event-related desynchronization, will be extracted in real time. When significant event-related desynchronization is detected, the system will trigger external feedback, such as a soft robotic glove or functional electrical stimulation, to assist the affected limb in completing the target movement.

05

What researchers measure

Primary outcomes

  1. Change in Fugl-Meyer Assessment for Upper Extremity Score

    The Fugl-Meyer Assessment for Upper Extremity will be used to evaluate motor function recovery of the affected upper limb.

    Time frame: Baseline, Week 4, Week 8, and Week 12

Secondary outcomes

  1. Change in Modified Ashworth Scale Score

    The Modified Ashworth Scale will be used to assess muscle tone and spasticity of the affected upper limb.

    Time frame: Baseline, Week 4, Week 8, and Week 12

  2. Change in Action Research Arm Test Score

    The Action Research Arm Test will be used to assess functional activity of the affected upper limb, including grasp, grip, pinch, and gross movement.

    Time frame: Baseline, Week 4, Week 8, and Week 12

  3. Change in Modified Barthel Index Score

    The Modified Barthel Index will be used to assess activities of daily living.

    Time frame: Baseline, Week 4, Week 8, and Week 12

  4. Incidence of Adverse Events and Serious Adverse Events

    All adverse events and serious adverse events will be recorded and assessed throughout the study. Spinal cord stimulation-related adverse events may include intraoperative or postoperative bleeding, infection, cerebrospinal fluid leakage, electrode migration or fracture, implant rejection, postoperative pain, and neurological injury. Motor imagery brain-computer interface-related adverse events may include dizziness, visual fatigue, skin allergy related to electrode gel, training-related fatigue, and other discomfort.

    Time frame: From enrollment to Week 12

Other outcomes

  1. Change in Electroencephalographic Indicators

    Resting-state and motor imagery task-state 64-channel electroencephalography will be collected to analyze event-related desynchronization/synchronization, phase-lag-index-based functional connectivity, and graph-theoretical topological properties.

    Time frame: Baseline, Week 4, and Week 12

  2. Change in Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Indicators

    Resting-state functional magnetic resonance imaging and diffusion tensor imaging will be performed to assess changes in functional connectivity of the default mode network and sensorimotor network, as well as fractional anisotropy and mean diffusivity of major white matter tracts, including the corticospinal tract.

    Time frame: Baseline and Week 12

06

Study locations

1 site
  • Zhejiang Provincial People's Hospital
    Hangzhou, Zhejiang 310014, China
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07686822
Lead sponsor
Zhejiang Provincial People's Hospital
Responsible party
Sponsor
First posted
Jul 7, 2026
Start date
Sep 2026 (estimated)
Primary completion
Feb 2028 (estimated)
Completion
May 2028 (estimated)
Last update
Jul 7, 2026

Study contacts

Faliang Gao, PhD
Contact
gaofaliang1985@126.com
+86-571-85893451

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion